Date posted: 27 February 2019
Closing date: 31 March 2019
CSL is currently implementing a Therapeutic Area (TA) model to support development of strategy and continued innovation. Strengthening focus on our defined TAs will be important in helping us to manage growth and our in-market and R&D portfolio going forward. As a result of the new TA model, we are seeking to appoint a Senior Director, Research, Haematology and Thrombosis. In this key leadership role within CSL Global Research, this position will contribute to the development and implementation of TA strategy, with a focus on the TA Research strategy and project portfolio.
Key responsibilities and accountabilities:
As a senior leader within the CSL Research function, this role provides expert scientific input into research activities within other CSL TA’s as appropriate (e.g. research project portfolio development and implementation, due diligence processes)
CSL Limited is a company that fosters a work culture emphasising Superior Performance, Innovation, Integrity, Collaboration and Customer Focus with a commitment to support, train and grow its people. As a genuine leader in the biopharmaceutical industry, CSL is a multinational ASX Listed Company that is actively growing its Australian based manufacturing operations to support global growth. CSL develops, manufactures and markets products to treat and prevent serious human medical conditions and is globally one of the largest manufacturers of plasma-derived therapies.
Applications must address selection criteria and include a current CV and cover letter. Please apply via the following link: Senior Director Research, Haematology & Thrombosis
Applications close Sunday, 31 March 2019
Employment screening, including criminal history, medical assessment, confirmation of experience and stated qualifications, Australian working rights and other relevant checks form part of the candidate suitability evaluation process.